Grown Rogue International (GRUSF) Non-Current Assets (2011 - 2026)

Grown Rogue International's (GRUSF) quarterly Non-Current Assets came in at $41.0 million in Q1 2026, up 90.58% year-on-year from $21.5 million in Q1 2025, and up 2334.24% quarter-over-quarter from $1.7 million in Q4 2025.

Grown Rogue International (GRUSF) Non-Current Assets (2011 - 2026) Analysis & Trends

Grown Rogue International's Non-Current Assets history runs 16 years deep, the most recent figure standing at $41.0 million for Q1 2026.

  • On a quarterly basis, Non-Current Assets rose 90.58% year-over-year to $41.0 million in Q1 2026; TTM through Mar 2026 was $72165.3 billion, a 100827772.62% increase from a year earlier, with the FY2025 full-year figure at $1.7 million, up 9.48% from the prior year.
  • Non-Current Assets grew to $41.0 million in Q1 2026 per GRUSF's latest filing, from $1.7 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $48078.5 billion in Q2 2025 and bottomed at $1.5 million in Q4 2024.
  • The 5-year median for Non-Current Assets is $13.9 million (2023), against an average of $5154.7 billion.
  • Across the five-year window, Non-Current Assets tumbled 85.05% in 2024 and soared 320009577.44% in 2025, its largest moves.
  • Year by year, Non-Current Assets stood at $8.5 million in 2022, then advanced by 21.58% to $10.3 million in 2023, then tumbled by 85.05% to $1.5 million in 2024, then climbed by 9.48% to $1.7 million in 2025, then surged by 2334.24% to $41.0 million in 2026.
  • Per Business Quant, the three latest GRUSF Non-Current Assets figures stand at $41.0 million (Q1 2026), $1.7 million (Q4 2025), and $24086.7 billion (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 36.78 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 26.33 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 8.68 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 79.20 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 3.84 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 15.70 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 25.92 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 2.47 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 9.64 Bn
10 Grown Rogue International 99.97 Mn 92.67 Mn 3.96 Mn 40.99 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 40.99 Mn
Dec 31, 2025 1.68 Mn
Sep 30, 2025 24,086.70 Bn
Jun 30, 2025 48,078.50 Bn
Mar 31, 2025 21.51 Mn
Dec 31, 2024 1.54 Mn
Sep 30, 2024 16.38 Mn
Jun 30, 2024 15.02 Mn
Mar 31, 2024 18.66 Mn
Dec 31, 2023 10.29 Mn
Oct 31, 2023 12.74 Mn
Apr 30, 2023 8.54 Mn
Jan 31, 2023 8.61 Mn
Oct 31, 2022 8.46 Mn
Oct 31, 2021 14.21 Mn
Apr 30, 2021 5.05 Mn
Jan 31, 2021 3.00 Mn
Oct 31, 2020 3.69 Mn
Jul 31, 2020 2.13 Mn
Apr 30, 2020 2.19 Mn